Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07203768 · ClinicalTrials.gov registry record
A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
A clinical trial of Polycythemia Vera and Thrombocythemia, sponsored by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS.
- Recruiting
- Registry status
- 678
- Enrollment target
- 20
- Study locations
NCT07203768: Recruiting study of Polycythemia Vera and Thrombocythemia, sponsored by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS.
NCT07203768 is a study of Polycythemia Vera and Thrombocythemia that is actively recruiting participants, run by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS. The registered enrollment target is 678 participants, above the 310-participant average among 22 other Polycythemia Vera trials with a reported enrollment target (119% higher). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07203768, a study of Polycythemia Vera and Thrombocythemia, is actively recruiting participants, sponsored by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS.
- RECRUITING
- Registry status
- 678 participants
- Enrollment target
- 20
- Study locations
Study Summary
International multicenter retrospective observational study consisting of two parts: a nested case-control study (part A) and a comparative retrospective cohort study (part B).
Primary Outcome
To identify proliferative risk factors for progression from ET to PV in JAK2V617F positive patients.
Conditions Studied
Study Locations (20)
Other
- University Hospital Halle - Halle
- Hannover Medical School - Hanover
- University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center - Minden
- A.S.O. SS. Antonio e Biagio e C.Arrigo, SC Ematologia - Alessandria
- ASST Papa Giovanni XXIII, SC Ematologia - Bergamo
- ASST-Spedali Civili - Brescia
- Ospedale Businco - Cagliari
- AOU Policlinico Vittorio Emanuele - PO Gaspare Rodolico - Catania
- AOU Careggi, Divisione di Ematologia - Florence
- ASST Grande Ospedale Metropolitano Niguarda, Divisione di Ematologia - Milan
- Fondazione IRCCS Cà Grande - Op. Maggiore Policlinico - Milan
- Ospedale San Raffaele - Milan
- ASST MONZA Ospedale San Gerardo Clinica Ematologica - Monza
- Azienda Ospedaliera Universitaria Federico II di Napoli Divisione di Ematologia e Trapianti del Midollo - Naples
- Azienda Ospedaliero Universitaria Maggiore della Carità di Novara SCDU Ematologia - Novara
- Presidio Ospedaliero di Pescara - Pescara
- Fondazione Policlinico Universitario Gemelli - Roma
Minnesota
- Mayo Clinic - Rochester
Lombardy
- Divisione Ematologia, Fondazione IRCCS Policlinico San Matteo - Pavia
Veneto
- Divisione Ematologia, Ospedale San Bortolo - Vicenza
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 678 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-07-31 |
What NCT07203768 shows while recruiting
NCT07203768 is an observational study that tracks outcomes without assigning an intervention. The registered 678 participants enrollment target is mid-sized for trials with a published cap, above the 310-participant average among 22 other Polycythemia Vera trials with a reported enrollment target (119% higher).
The record links to 2 conditions, with Polycythemia Vera appearing as the primary indexed condition, and to 0 interventions.
NCT07203768 names 20 study sites across 4 states, led by Other, Minnesota, Lombardy.
Frequently Asked Questions
What is clinical trial NCT07203768 about?
NCT07203768 is a clinical study titled "A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes". International multicenter retrospective observational study consisting of two parts: a nested case-control study (part A) and a comparative retrospective cohort study (part B).
What is the current status of trial NCT07203768?
This trial is currently recruiting. The enrollment target is 678 participants. The study started on 2025-12-01. Estimated completion is 2026-07-31.
What conditions does trial NCT07203768 study?
This clinical trial studies the following conditions: Polycythemia Vera, Thrombocythemia.
Who is sponsoring clinical trial NCT07203768?
This trial is sponsored by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07203768 being conducted?
This trial has 20 study locations across Minnesota, Lombardy, Veneto. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polycythemia Vera
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07203768's enrollment target sits among peer trials
678 2nd of 22 the highest of 22 other Polycythemia Vera trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Polycythemia Vera trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RECRUITING · Phase 2
-
Ruxolitinib in Thrombocythemia and Polycythemia Vera
RECRUITING · Phase 2
-
Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
RECRUITING · Phase 1
-
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
RECRUITING · Phase 3
-
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
RECRUITING
-
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05372484 · 678 participants · NA
Rice Technologies for Cervical Cancer Screening and Diagnosis
- NCT06436924 · 678 participants
Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day
- NCT03501706 · 680 participants · NA
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
- NCT05626452 · 680 participants · NA
PrEP Optimization Among Women to Enhance Retention and Uptake
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI